Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation

Ciftciler, Rafiye; GÖKER, HAKAN; BÜYÜKAŞIK, YAHYA; KARAAĞAÇ AKYOL, TÜLAY; AKSU, SALİH; Tekin, Fatma; DEMİROĞLU, HALUK

doi:10.1016/j.transci.2019.06.024

Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., KARAAĞAÇ AKYOL T., AKSU S., Tekin F., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 59 Sayı: 1
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.transci.2019.06.024
Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, EMBASE, MEDLINE
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Background and aim: ABO and Rh compatibility are not required between the donor and recipient for allogeneic hematopoietic stem cell transplantation (alloHSCT). Although ABO incompatibility is not considered a contraindication in alloHSCT, its clinical outcomes are still doubtful. In this study, we analyzed the neutrophil and platelet recovery, graft versus host disease (GVHD), relapse rate, mortality rate, non-relapse mortality and survival in patients who underwent alloHSCT.